Tejada-Simon M V, Zang Y C, Yang D, Hong J, Li S, Singh R A, Van den Berg-Loonen E, Killian J M, Rivera V M, Zhang J Z
Multiple Sclerosis Research Laboratory, Baylor-Methodist Multiple Sclerosis Center and Department of Neurology, Houston, TX 77030, USA.
Int Immunol. 2000 Dec;12(12):1641-50. doi: 10.1093/intimm/12.12.1641.
Multiple sclerosis (MS) is a demyelinating disease of presumed T cell autoimmunity against self myelin. We hypothesized that if myelin-reactive T cells are associated with the disease processes, they may undergo activation and expansion during acute exacerbation. In this study, we examined the precursor frequency, epitope recognition and cytokine profile of myelin-reactive T cells in 14 relapsing/remitting MS patients during exacerbation and remission. The study revealed that T cells recognizing the immunodominant peptides of candidate myelin antigens, including myelin basic protein (MBP), proteolipid protein and myelin oligodendrocyte glycoprotein, occurred at increased precursor frequency during acute exacerbation. The T cell responses to MBP focused on the immunodominant regions (residues 83-99 and 151-170) during exacerbation and shifted toward other epitopes of MBP at the time of remission. Furthermore, there was a marked increase in the production of T(h)1 cytokines among T cell lines obtained during exacerbation compared to those obtained during remission. The study demonstrated that myelin-reactive T cells underwent selective activation and expansion during acute MS exacerbation. In contrast, myelin-reactive T cells found during remission in the same patients generally resembled those identified in healthy controls with some discrepancies. The findings suggest potential association of aberrant myelin-reactive T cell responses with acute exacerbation in MS, which may reflect transient activation of myelin-reactive T cell populations of pathogenic potential.
多发性硬化症(MS)是一种推测由针对自身髓鞘的T细胞自身免疫引起的脱髓鞘疾病。我们假设,如果髓鞘反应性T细胞与疾病进程相关,那么它们可能在急性发作期发生激活和扩增。在本研究中,我们检测了14例复发/缓解型MS患者在发作期和缓解期髓鞘反应性T细胞的前体频率、表位识别及细胞因子谱。研究显示,识别候选髓鞘抗原(包括髓鞘碱性蛋白(MBP)、蛋白脂蛋白和髓鞘少突胶质细胞糖蛋白)免疫显性肽段的T细胞,在急性发作期前体频率增加。T细胞对MBP的反应在发作期集中于免疫显性区域(第83 - 99位和151 - 170位氨基酸残基),而在缓解期则转向MBP的其他表位。此外,与缓解期获得的T细胞系相比,发作期获得的T细胞系中T(h)1细胞因子的产生显著增加。该研究表明,髓鞘反应性T细胞在MS急性发作期经历了选择性激活和扩增。相比之下,同一患者缓解期发现的髓鞘反应性T细胞通常与健康对照中识别出的T细胞相似,但存在一些差异。这些发现提示异常的髓鞘反应性T细胞反应与MS急性发作可能存在潜在关联,这可能反映了具有致病潜力的髓鞘反应性T细胞群体的短暂激活。